69 related articles for article (PubMed ID: 22765024)
1. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients.
Ferraresso M; Belingheri M; Turolo S; Ghio L; Tirelli AS; Grillo P; Lepore M; Edefonti A
Pharmacogenomics; 2013 Oct; 14(13):1605-13. PubMed ID: 24088131
[TBL] [Abstract][Full Text] [Related]
3. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism.
Fanta S; Jönsson S; Karlsson MO; Niemi M; Holmberg C; Hoppu K; Backman JT
J Clin Pharmacol; 2010 May; 50(5):581-97. PubMed ID: 20107201
[TBL] [Abstract][Full Text] [Related]
4. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
Gençtoy G; Kahraman S; Arici M; Altun B; Erdem Y; Bakkaloğlu M; Yasavul U; Turgan C
Transplant Proc; 2006 Mar; 38(2):521-8. PubMed ID: 16549165
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
[TBL] [Abstract][Full Text] [Related]
8. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
9. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
Dominguez J; Kompatzki A; Velasco A; Turpaud F; Norambuena R; Arenas J; Pais E; Llanos R; Cortes-Monroy G
Transplant Proc; 2005 Oct; 37(8):3358-60. PubMed ID: 16298595
[TBL] [Abstract][Full Text] [Related]
10. Outcome of renal transplants from pediatric donors <5 yr of age.
El-Sabrout R; Buch K
Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791
[TBL] [Abstract][Full Text] [Related]
11. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
[TBL] [Abstract][Full Text] [Related]
12. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
Hoyer PF
Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
[TBL] [Abstract][Full Text] [Related]
14. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
15. The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.
Tirelli S; Ferraresso M; Ghio L; Meregalli E; Martina V; Belingheri M; Mattiello C; Torresani E; Edefonti A
Med Sci Monit; 2008 May; 14(5):CR251-254. PubMed ID: 18443548
[TBL] [Abstract][Full Text] [Related]
16. [MMF and CyA in the prevention of early acute rejection after renal transplantation].
He B; Han X; Liu J; Han Z; Guan D; Gao J
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):683-5. PubMed ID: 11832139
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
Qazi YA; Forrest A; Tornatore K; Venuto RC
Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Trompeter R; Filler G; Webb NJ; Watson AR; Milford DV; Tyden G; Grenda R; Janda J; Hughes D; Ehrich JH; Klare B; Zacchello G; Bjorn Brekke I; McGraw M; Perner F; Ghio L; Balzar E; Friman S; Gusmano R; Stolpe J
Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
[TBL] [Abstract][Full Text] [Related]
19. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
[TBL] [Abstract][Full Text] [Related]
20. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
